Lev1g 0007 01
Levetiracetam In Sodium Chloride Injection
Product Images NDC 14789-110
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Levetiracetam In Sodium Chloride (NDC 14789-110). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Nexus Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Lev1g 0007 02
Lev1g 0007 03
Lev1g 0007 04
Lev1g 0007 05
Lev1g 0007 06
Lev1g 0007 07
Levetiracetam in 0.82% Sodium Chloride Injection is a medication that is intended for intravenous use only. It is recommended to infuse it over a period of 15 minutes. Each 100 mL contains 500 mg levetiracetam, 820 mg sodium chloride, 5.5 mg of glacial acetic acid and buffered at around pH 5.5 with glacial acetic acid and 164 mg sodium acetate trihydrate. The medication is stored at 20°C to 25°C (68°F to 77°F) and should not be further diluted prior to use. The package insert should be consulted for the usual dosage. Levetiracetam in 0.82% Sodium Chloride Injection comes in single-use bags packaged in an aluminum overwrap and inner polypropylene overwrap.*
Lev1g 0007 08
NDC 14789-110-08 is a prescription-only medication containing Levetiracetam in Sodium Chloride Injection. It is available in a 100 mL single-dose container to be used for intravenous infusion only. The container should not be diluted before use, and the medication should be infused over a period of 15 minutes. The medication should be used promptly after opening the overwrap. The usual dosage should be determined based on the package insert. The medication should be stored at 20 to 25°C (68 to 77°F) and should not be stored in plastic containers in series. The medication is manufactured in the UK for Nexus Pharmaceuticals, Inc. and is a single-use dual port bag. Specific lot and expiration information is not available.*
Lev1g 0007 09
Levetiracetam is a medication that is intended for intravenous infusion only for use as per the package insert. Each 100L of the medication includes 1000mg of levetiracetam and is infused over a period of 15 minutes. The medication is packaged in plastic overwrap and is not recommended for use if the overwrap has already been opened or damaged before use. The solution of the medication includes 750g of sodium chloride, 6.5m of glacial acetic acid, and is buffered to pH 5.5. The recommended storage temperature for the medication is between 20°C to 25°C. The container closure does not contain natural rubber latex.*
Lev1g 0007 10
This is a prescription medicine with the NDC code 14789-220-08. It is a single-dose container containing 100 mL of Levetiracetam in 0.75% Sodium Chloride Injection with a concentration of 1000 mg/100 mL (10 mg/mL). It should be infused over a period of 15 minutes and should not be further diluted prior to use. The usual dosage should be referred to in the package insert. The medication should not be used with plastic containers in series connections. The recommended storage is at 20 to 25°C (68 to 77°F). It is a single-use dual port bag manufactured in the UK for Nexus Pharmaceuticals, Inc. in Lincolnshire, IL.*
Lev1g 0007 11
This is a medication called Levetiracetam that is infused intravenously over a 15-minute period. The usual dosage is specified in the package insert. Each 100ml of Levetiracetam injection contains 1500mg of levetiracetam, water for injection, 540 mg of sodium chloride, and 7.5 mg of glacial acetic acid. The solution is buffered at about pH 5.5 by glacial acetic acid and 164 g of sodium acetate trihydrate. The medication is stored in single-use bags that are wrapped in plastic overwrap. The wrap should be removed and checked for leaks before use. The medication should be used promptly once the plastic overwrap is removed. The instruction specifies that plastic containers should not be used in series connections. Lastly, the container closure is not made of natural rubber latex, and the medication is only for intravenous infusion.*
Lev1g 0007 12
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
